These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33033523)
21. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells. Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650 [TBL] [Abstract][Full Text] [Related]
22. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition. Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731 [TBL] [Abstract][Full Text] [Related]
23. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer. Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216 [TBL] [Abstract][Full Text] [Related]
24. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3. Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA regulatory pathway analysis identifies miR-142-5p as a negative regulator of TGF-β pathway via targeting SMAD3. Ma Z; Liu T; Huang W; Liu H; Zhang HM; Li Q; Chen Z; Guo AY Oncotarget; 2016 Nov; 7(44):71504-71513. PubMed ID: 27683030 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228 [TBL] [Abstract][Full Text] [Related]
27. miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway. Liu Y; Chen J RSC Adv; 2018 Dec; 9(1):151-165. PubMed ID: 35521597 [No Abstract] [Full Text] [Related]
28. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426 [TBL] [Abstract][Full Text] [Related]
29. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A. Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787 [TBL] [Abstract][Full Text] [Related]
30. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer. Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173 [TBL] [Abstract][Full Text] [Related]
31. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038 [TBL] [Abstract][Full Text] [Related]
32. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II. Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417 [TBL] [Abstract][Full Text] [Related]
33. miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer. Qi JC; Yang Z; Zhang YP; Lu BS; Yin YW; Liu KL; Xue WY; Qu CB; Li W Front Oncol; 2019; 9():1535. PubMed ID: 32010624 [TBL] [Abstract][Full Text] [Related]
34. EPA attenuates epithelial-mesenchymal transition and fibrosis through the TGF-β1/Smad3/ILK pathway in renal tubular epithelial HK-2 cells by up-regulating miR-541. Wei Z; Cao J; Zhang X; Yin D; Xu D; Lu G Int J Clin Exp Pathol; 2019; 12(7):2516-2525. PubMed ID: 31934078 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells. Feili X; Wu S; Ye W; Tu J; Lou L Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931 [TBL] [Abstract][Full Text] [Related]
37. miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway. Wei S; Li Q; Li Z; Wang L; Zhang L; Xu Z Oncotarget; 2016 Nov; 7(46):75185-75196. PubMed ID: 27655675 [TBL] [Abstract][Full Text] [Related]
38. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
39. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B. Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-198-5p inhibits the migration and invasion of non-small lung cancer cells by targeting fucosyltransferase 8. Wang S; Zhang X; Yang C; Xu S Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):955-967. PubMed ID: 31381176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]